Lumixyl Treats Skin Discoloration without Side Effects
Many people with skin discoloration have turned to hydroquinone and other skin lightening agents to help brighten up the skin and reduce pigmentation. However, recent studies in Europe have shown that hydroquinone can be harmful to one’s health and may have some toxic side effects. Other skin lightening agents may cause hyperpigmentation or hypopigmentation of the skin, resulting in an even more uneven skin tone.
Fortunately, there are now other options. At the annual meeting of the American Academy of Dermatology this March, Keith Veseleny, Editor of American Health & Beauty, talked about the benefits of Lumixyl, a new skin lightening compound that can effectively reduce age spots, brown spots and signs of sun damage on all types of skin.
Mr. Veseleny explains, "Traditionally we have hydroquinone which is used for this purpose, but now we have something else. It’s really an exciting product…it’s exciting because it’s a natural peptide that’s used and it doesn’t have any cytotoxic properties, and it’s shown to be quite effective in helping with skin pigmentation."
Lumixyl can be used to treat a number of pigmentation problems including post-inflammatory hyperpigmentation, melasma and superficial pigmentation from the sun or scars. Dr. Ashish Bhatia, a board certified dermatologist in Chicago, reports that he is already using Lumixyl to treat sunspots and age spots, and it can even be used to treat seborrheac keratosis and lesions that are not responding to hydroquinone treatments.
Lumixyl can be used on all skin types, and is not irritating. It may be used in conjunction with a glycolic acid so that skin cells can turn over quickly, and can be delivered deeper into the skin using microdermabrasion and silk peels.
Dr. Bhatia says that Lumixyl is a “perfect compliment” to many other cosmetic procedures, and is an attractive option for patients that want to improve their skin tone and achieve results in a short period of time.
Cosmetic Surgery Review, March 17, 2010
CBS Channel 5 News Nashville, March 2010
Announcing the Lumixyl(TM) Brightening System, a New Physician-Grade System Designed to Safely Address the Signs of Hyperpigmentation.
NEW YORK, March 9 /PRNewswire/ -- Envy Medical, Inc., introduces the new Lumixyl ™Brightening System, a revolutionary multi-faceted approach to effectively treat hyperpigmentation without irritation or other side effects associated with prescription Hydroquinone or retinoids. This professional skincare system introduction builds onthe success of the Lumixyl Topical Brightening Creme introduced in 2009.
"The Lumixyl Topical Brightening System is an entirely new approach to naturally brighter, more vibrant skin, representing a new physician-grade standard in skincare," explains Dr. Basil Hantash, MD, PhD, a board certified Stanford-trained dermatologist and vice-chairman of the board at Envy Medical, who also helped develop the Lumixyl peptide technology.
An innovation in skin brightening technology, the four products in the Lumixyl Brightening System work synergistically to target existing hyperpigmentation and to prevent its recurrence. For most patients these formulations can eliminate the need to use hydroquinone or its bi-products, which are controversial due to their potential side effects. Lumixyl products are proven to be powerful but gentle on skin.
"Physicians and the public at large have been calling for a viable alternative to prescription hydroquinone therapies," commented Envy Medical CEO, Curtis A. Cluff. "We are very pleased to be able to answer that call with a system that provides visible brightening with a safe and non-irritating formula."
The Lumixyl Topical Brightening System builds on the four products including Active-Prep Cleanser, the Topical Brightening Creme, GlycoPeel 20 Rapid Exfoliating Lotion, and Moisture-Lock Sunscreen SPF 30. The products are ideal for all skin types. Lumixyl Brightening System retails for $270 for four full size products.
Developed by Envy Medical, Inc. and dermatological researchers at Stanford University, Lumixyl products are made exclusively for dermatologists, plastic surgeons and skin oriented aesthetic physicians. The products are manufactured and sold by Envy Medical in the United States and distributed internationally by Toronto Canada-based BASIS Medical Technologies.
ABOUT BASIS - BASIS Medical Technologies specializes in the development and distribution of groundbreaking technologies in medicine and medical aesthetics. Headquartered in Toronto, Canada, BASIS is an innovative technology platform with sales, marketing and training capabilities around the world. With an experienced management team and medical advisory panel, BASIS is committed to delivering and developing cutting-edge medical products internationally. BASIS is an exclusive market representative for Lumixyl in markets throughout the world, a product licensed by Envy Medical Inc.
ABOUT ENVY MEDICAL - Envy Medical develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. The Company's lead products include SilkPeel®, a breakthrough device combining exfoliation with dermalinfusion® for deeper tissue delivery of active ingredients and better patient outcomes. Envy is also the exclusive licensor of skin brightening peptides including Lumixyl, developed at Stanford University. The Lumixyl peptide is now also available as a topical solution for SilkPeel procedures, addressing hyperpigmentation and photo-damage. More information can be found at www.envymedical.com.
As much as we appreciate a product that offers multiple benefits, there's something very reassuring about a formula intended for a single skin-improving purpose. Lumixyl Topical Brightening Cream, for example, is completely committed to reducing discoloration.
Lumixyl is touted as "a skin brightening peptide," but it's actually a special decapeptide surrounded by other supportive ingredients, like licorice root, Indian gooseberry and meadowfoam seed oil. Together, they effectively address age spots, unevenness, and post-inflammatory hyperpigmentation.
Say hello to Lumixyl during your next visit to the dermatologist. This non-toxic, non-irritating synthetic peptide formula uses naturally occurring amino acids to target discoloration and dark spots on the skin. Clinical studies showed a 40% improvement in participants melasma, post-inflammatory hyperpigmentation (..like fresh acne scars), sun spots and photo damage…and probably the best part about Lumixyl is that it is approved for longterm use (you’re only supposed to use Triluma for up to 8 weeks.).
On a recent trip to Palm Beach, I succumbed to a much needed Day of Beauty at my favorite girl’s haunt – the gorgeous 12,000 cosmedical mecca known as Anushka Spa in CityPlace. I was visiting to attend the L’Oreal 100th Birthday Gala along with two hundred of the Palm Beach elite and a dozen members of the local press. After making three long trips in three weeks, my skin, hair and nails had taken a major beating and I would have allowed myself to be talked into almost anything. My first and most vital step was an appointment at the Spa to rehydrate my deadly complexion.
The Latest Fashion News, Trends and Updates, October 27th, 2009
The Lumixyl Experiment.
I have been dealing with hyperpigmentation for years. As I get older, it inevitably gets worse. Much worse. I actually went to the dermatologist recently and have a prescription, for which I have yet to fill. Why not? First off, I am hesitant to use it with its’ high concentration of hydroquinone. Don’t get me wrong, if all else fails, I will try it. Second, I just read about this new hydroquinone alternative called Lumixyl, and I want to give it a try first.
Lumixyl is a brand new skin brightening cream that claims to be non-irritating. It contains a newly found synthetic peptide technology that has been helping to improve the appearance of unwanted discoloration, age spots, sun spots and uneven skin tone.
Hand Rejuvenation: A One-Two Punch for Younger Looking Hands
By Bryan G. Forley, M.D., F.A.C.S.
Your hands age along with your face. Due to the constant daily exposure to ultraviolet rays, your hands may reveal your true chronological age even more than other parts of your body. The aging process in the hands is characterized by wrinkled skin, increased pigmentation, and prominent veins and tendons as soft tissues break down. These frequently neglected visible signs of aging can be a stark contrast to a more youthful appearing face that has benefited from the many available options for surgical and non-surgical rejuvenation.
Most women use various creams and ointments to beautify their skin. These topical treatments just don’t go deep enough for optimum effect.
SilkPeel Dermalinfusion is a new treatment that delivers specialized solutions deep into the skin. This technology utilizes a mild vacuum to pull the skin up slightly, and adds a small amount of vibration. Combined with solutions that contain elements fine enough to actually be absorbed by the skin, it’s like putting on a fresh new face, instantly.
Discoloration, sun spots, melasma, hyper pigmentation all add years to your complexion. Before, the only place to turn was hydroquinone, but this topical treatment has come under intense fire for potentially dangerous side effects. Because of its suspected toxicity, many women can not get proper treatment for their skin. Enter Lumixyl, a new topical treatment. Developed by dermatologists at Stanford University, the peptide solution restrains tyrosine, the enzyme responsible for initiating the overproduction of melanin, which causes uneven pigmentation and dark spots.
